全球COVID-19大流行在评估与大流行相关的痛苦方面看到了显著的研究和临床兴趣,即对感染和死亡的恐惧和焦虑。最广泛使用和最早开发的COVID-19窘迫措施是Ahorsu等人。(2022)对COVID-19量表(FCV-19S)的七个项目恐惧。为了研究FCV-19S的因子结构和测量等效性,我们进行了一项项目水平的荟萃分析,综合了k=55个独立样本(包括N=71,161个个体)的1155个效应大小.我们发现,包含四项情绪因素和三项心身因素的双因素测量模型比最初提出的单因素测量模型具有更好的拟合度。此外,二维FCV-19S在一般人群中表现出部分标量/强不变性,医护人员,学校教师,和大学生,以及来自孟加拉国样本的部分度量/弱不变性,中国,Japan,巴基斯坦,波兰,葡萄牙。尽管这些发现具有理论和实践意义,在更广泛的样本类型和国家的更多的主要研究无疑是需要进一步评估FCV-19S的心理测量特性和普遍性。
The global COVID-19 pandemic saw marked research and clinical interest in evaluating pandemic-related distress, namely fear and anxiety regarding infection and death. The most widely used and earliest developed measure of COVID-19 distress is Ahorsu et al. (2022) seven-item Fear of COVID-19 Scale (FCV-19S). To investigate the factor structure and measurement equivalence of the FCV-19S, we conducted an item-level meta-analysis synthesizing 1155 effect sizes across k = 55 independent samples comprising N = 71,161 individuals. We found that a two-factor measurement model comprising a four-item Emotional factor and a three-item Psychosomatic factor exhibits better fit than the originally proposed single-factor measurement model. Moreover, the bidimensional FCV-19S exhibits partial scalar/strong invariance across the general population, healthcare workers, schoolteachers, and university students as well as partial metric/weak invariance across samples from Bangladesh, China, Japan, Pakistan, Poland, and Portugal. Despite the theoretical and practical implications of these findings, more primary research across a wider range of sample types and countries is undoubtedly needed for further evaluation of the FCV-19S\'s psychometric properties and generalizability.